1-7 of 7
Nicholas J. Donato
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abrogation of Signal Transducer and Activator of Transcription 3 Reactivation after Src Kinase Inhibition Results in Synergistic Antitumor Effects

Faye M. Johnson, Babita Saigal, Hai Tran, Nicholas J. Donato
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (14): 4233–4244.
https://doi.org/10.1158/1078-0432.CCR-06-2981
Published: 18 July 2007
View articletitled, Abrogation of Signal Transducer and Activator of Transcription 3 Reactivation after Src Kinase Inhibition Results in Synergistic Antitumor Effects
Open the PDF for Abrogation of Signal Transducer and Activator of Transcription 3 Reactivation after Src Kinase Inhibition Results in Synergistic Antitumor Effects in another window
Journal Articles

Phase I Clinical and Pharmacodynamic Evaluation of Oral CI-1033 in Patients with Refractory Cancer

Ralph G. Zinner, John Nemunaitis, Irene Eiseman, Hyung Ju C. Shin, Stephen C. Olson, James Christensen, Xin Huang, Peter F. Lenehan, Nicholas J. Donato, Dong M. Shin
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (10): 3006–3014.
https://doi.org/10.1158/1078-0432.CCR-06-1958
Published: 15 May 2007
View articletitled, Phase I Clinical and Pharmacodynamic Evaluation of Oral CI-1033 in Patients with Refractory Cancer
Open the PDF for Phase I Clinical and Pharmacodynamic Evaluation of Oral CI-1033 in Patients with Refractory Cancer in another window
Journal Articles

Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non–Small Cell Lung Cancer Cells

Faye M. Johnson, Babita Saigal, Moshe Talpaz, Nicholas J. Donato
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (19): 6924–6932.
https://doi.org/10.1158/1078-0432.CCR-05-0757
Published: 03 October 2005
View articletitled, Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non–Small Cell Lung Cancer Cells
Open the PDF for Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non–Small Cell Lung Cancer Cells in another window
Journal Articles

Superior Therapeutic Profile of Poly-l-Glutamic Acid-Paclitaxel Copolymer Compared with Taxol in Xenogeneic Compartmental Models of Human Ovarian Carcinoma1

Edmond Auzenne, Nicholas J. Donato, Chun Li, Elena Leroux, Roger E. Price, David Farquhar, Jim Klostergaard
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (2): 573–581.
Published: 01 February 2002
View articletitled, Superior Therapeutic Profile of Poly-l-Glutamic Acid-Paclitaxel Copolymer Compared with Taxol in Xenogeneic Compartmental Models of Human Ovarian Carcinoma1
Open the PDF for Superior Therapeutic Profile of Poly-l-Glutamic Acid-Paclitaxel Copolymer Compared with Taxol in Xenogeneic Compartmental Models of Human Ovarian Carcinoma1 in another window
Journal Articles

Epidermal Growth Factor Receptor-targeted Therapy with C225 and Cisplatin in Patients with Head and Neck Cancer

Dong M. Shin, Nicholas J. Donato, Roman Perez-Soler, Hyung Ju C. Shin, Ji Y. Wu, Peter Zhang, Kristie Lawhorn, Fadlo R. Khuri, Bonnie S. Glisson, Jeffrey Myers, Gary Clayman, David Pfister, John Falcey, Harlan Waksal, John Mendelsohn, Waun Ki Hong
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (5): 1204–1213.
Published: 01 May 2001
View articletitled, Epidermal Growth Factor Receptor-targeted Therapy with C225 and Cisplatin in Patients with Head and Neck Cancer
Open the PDF for Epidermal Growth Factor Receptor-targeted Therapy with C225 and Cisplatin in Patients with Head and Neck Cancer in another window
Journal Articles

Clinical Use of Tyrosine Kinase Inhibitors: Therapy for Chronic Myelogenous Leukemia and Other Cancers

Nicholas J. Donato, Moshe Talpaz
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (8): 2965–2966.
Published: 01 August 2000
View articletitled, Clinical Use of Tyrosine Kinase Inhibitors: Therapy for Chronic Myelogenous Leukemia and Other Cancers
Open the PDF for Clinical Use of Tyrosine Kinase Inhibitors: Therapy for Chronic Myelogenous Leukemia and Other Cancers in another window
Journal Articles

EGF Receptor and p21WAF1 Expression are Reciprocally Altered as ME-180 Cervical Carcinoma Cells Progress from High to Low Cisplatin Sensitivity

Nicholas J. Donato, Margot Perez, Hyunseok Kang, Zahid H. Siddik, Yi-He Ling, Roman Perez-Soler
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (1): 193–202.
Published: 01 January 2000
View articletitled, EGF Receptor and p21WAF1 Expression are Reciprocally Altered as ME-180 Cervical Carcinoma Cells Progress from High to Low Cisplatin Sensitivity
Open the PDF for EGF Receptor and p21WAF1 Expression are Reciprocally Altered as ME-180 Cervical Carcinoma Cells Progress from High to Low Cisplatin Sensitivity in another window